ClinConnect ClinConnect Logo
Search / Trial NCT06222242

mychoiceTM Implementation With Medical Oncology Patients

Launched by FOX CHASE CANCER CENTER · Jan 22, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Cancer

ClinConnect Summary

This clinical trial, called mychoiceTM Implementation With Medical Oncology Patients, is looking at how well a new tool called mychoiceTM works for patients with cancer. The goal is to see if this tool can help patients talk to their doctors about clinical trials as a treatment option during their cancer care. The study is currently recruiting participants and aims to understand how easy and helpful it is for patients to use this tool after their first visit with an oncology provider.

To be eligible for the trial, participants need to be at least 18 years old, speak and read English, and have been diagnosed with cancer. They should also have provided a cell phone number or email address in their medical records. If you join the study, you can expect to receive the mychoiceTM tool and share your experiences about it with the research team. This feedback will help determine how valuable the tool is for improving conversations about treatment options in oncology.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or over
  • Able to speak and read English
  • Medical Oncology patients who have had their initial visit
  • Have a cell phone number and/or an email in the electronic medical record
  • Exclusion Criteria
  • Doesn't not speak or read English
  • Patients who do not have a cancer diagnosis

About Fox Chase Cancer Center

Fox Chase Cancer Center is a leading academic research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and cutting-edge research. As a National Cancer Institute-designated Comprehensive Cancer Center, it combines a multidisciplinary approach with a commitment to patient-centered care, fostering collaboration among experts in oncology, surgery, radiation therapy, and supportive care. Fox Chase is renowned for its pioneering contributions to cancer research, translating discoveries into effective therapies and improving patient outcomes, while also prioritizing education and community outreach to enhance public awareness of cancer prevention and treatment options.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Linda Fleisher, PhD, MPH

Principal Investigator

Fox Chase Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported